It is the standard for pain management for cancer pain
treatment according to foreign guidelines.
The report provides a snapshot of the global therapeutic landscape of Cancer Pain
A review of the Cancer Pain
products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
Oncology nurses are noted as being at the frontline of cancer pain
management (Aycock & Boyle, 2009).
caused by medical interventions or treatment is classed as acute (short term) or chronic (long term)2.
The concept of cancer and cancer pain
has become more prevalent in the world.
The Gopi has uncovered a pandemic of overregulation in much of the developing world that is making it catastrophically difficult to provide basic medication to relieve strong cancer pain
," said Nathan Cherny, ESMO Palliative Care Working Group Chair, lead author of the report, Shre Zedek Medical Center, Israel.
Still, the evidence is growing that pain is a multisystemic, multifactorial challenge, felt more acutely in the face of fear or stress, so the wise guidance of those who treat "Dueling Diagnoses" will add value to the treatment of cancer pain
, even in the most straightforward of cases.
15 June 2011 - Swedish pharma company Orexo AB (STO: ORX) announced on Tuesday the launch of its cancer pain
drug Abstral in Canada by local partner Paladin Labs Inc (TSE: PLB).
The researcher will understand the challenges described in clinical trial designs while the importance of education of medical students about cancer pain
is stressed - but this should be a continuum through house officer years when medical officers develop the attitudes and skills that they take into general practice or specialty training.
A symposium sponsored by the International Association for the Study of Pain brought together clinical and basic scientists from around the world to discuss current issues related to cancer pain
and to develop a research agenda to guide future work.
Orexo AB (STO: ORX) has announced that an exclusive licensing and distribution agreement has been signed with NewBridge Pharmaceuticals for Abstral, Orexo's product for the treatment of breakthrough cancer pain
Breakthrough cancer pain
(BTCP) is different from ongoing, persistent pain.
DRUGS USED TO TREAT CANCER PAIN
MAY PROMOTE TUMOR SPREAD.
The purpose of this paper is to present a review of the research studies conducted on pediatric cancer pain
over 13-1/2 years.